Bone mineral density and its determinants in men with opioid dependence
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Data on the influence of opioid substitution therapy (OST) on skeletal health in men is limited. This cross-sectional study aimed to determine the prevalence of low bone mass in male drug users and to evaluate the relationship between endogenous testosterone and bone mass. We recruited 144 men on long-term opioid maintenance therapy followed in the Center of Addiction Medicine in Basel, Switzerland. Data on medical and drug history, fracture risk and history of falls were collected. Bone mineral density (BMD) was evaluated by densitometry and serum was collected for measurements of gonadal hormones and bone markers. 35 healthy age- and BMI-matched men served as the control group. The study participants received OST with methadone (69 %), morphine (25 %) or buprenorphine (6 %). Overall, 74.3 % of men had low bone mass, with comparable bone mass irrespective of OST type. In older men (≥40 years, n = 106), 29.2 % of individuals were osteoporotic (mean T-score -3.0 ± 0.4 SD) and 48.1 % were diagnosed with osteopenia (mean T-score -1.7 ± 0.4 SD). In younger men (n = 38), 65.8 % of men had low bone mass. In all age groups, BMD was significantly lower than in age-and BMI-matched controls. In multivariate analyses, serum free testosterone (fT) was significantly associated with low BMD at the lumbar spine (p = 0.02), but not at the hip. When analysed by quartiles of fT, lumbar spine BMD decreased progressively with decreasing testosterone levels. We conclude that low bone mass is high…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, higher serum concentrations of the bone resorption marker β C-terminal telopeptide were reported in male heroin users compared to healthy volunteers (222), a finding replicated in men receiving opioid substitution therapy (223).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [223]
In the citing paper
“whereas free testosterone was shown to be an independent predictor of bone mass (223).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [223]
In the citing paper
“predominantly on the axial skeleton in 73% of participants (223).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [223]
In the citing paper
“reported a decreased BMD compared to compared to age-and BMI-matched healthy controls”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [223]
In the citing paper
“In all age groups, BMD was significantly lower than in age-and BMI-matched controls”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [223]
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 2×
“[30].”
Method(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
Glüer, C. C., Blake, G., Lu, Y., Blunt1, B. A., Jergas1, M., & Genant1, H. K. (1995) · Osteoporosis International · doi:10.1007/bf01774016 · Cited by 1,282 · cited 1×
“To assess the short-term precision of the system, single repeat measurements in 20 patients were performed [31].”
MethodSmoking and fracture risk: a meta-analysis
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J. A., Fujiwara, S., Kroger, H., McCloskey, E. V., Mellstrom, D., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1640-3 · Cited by 999
Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401 · cited 2×
“Long-term opioid therapy for either addiction or chronic pain induces hypogonadism [17–21] due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropin-releasing hormone in the pituitary gland and impaired testicular function [23].”
BackgroundAssociation Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density
Berg, K. M., Kunins, H. V., Jackson, J. L., Nahvi, S., Chaudhry, A., Harris, K. A., Malik, R., & Arnsten, J. H. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.12.012 · Cited by 328 · cited 2×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundMonoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum
Gomez, B., Ardakani, S., Ju, J., Jenkins, D., Cerelli, M. J., Daniloff, G. Y., & Kung, V. T. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.11.1560 · Cited by 312 · cited 1×
“6 %, respectively [26].”
The impact of opioids on the endocrine system
Katz, N., & Mazer, N. A. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181850df6 · Cited by 307 · cited 2×
“1 3 pain induces hypogonadism due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropins in the pituitary gland and impaired testicular function [22, 23].”
BackgroundFracture risk associated with the use of morphine and opiates
VESTERGAARD, P., REJNMARK, L., & MOSEKILDE, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01667.x · Cited by 244 · cited 2×
“Several population-based and case–control studies indicate that opioid drugs used for medical reasons such as pain relief are associated with an increased risk of fractures [32, 33].”
BackgroundBliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., & Klingmüller, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0929 · Cited by 236 · cited 2×
“Long-term opioid therapy for either addiction or chronic pain induces hypogonadism [17–21] due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropin-releasing hormone in the pituitary gland and impaired testicular function [23].”
BackgroundOsteoporosis is markedly underdiagnosed: a nationwide study from Denmark
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1680-8 · Cited by 227 · cited 1×
“Because bone loss occurs insidiously and is initially asymptomatic, osteoporosis is often only diagnosed after the first clinical fracture has occurred [2].”
BackgroundSymptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. (2004) · Cancer · doi:10.1002/cncr.20028 · Cited by 206 · cited 2×
“Long-term opioid therapy for either addiction or chronic pain induces hypogonadism [17–21] due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropin-releasing hormone in the pituitary gland and impaired testicular function [23].”
BackgroundPsychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204 · cited 2×
“Negative influences on bone mineral density and fracture risk with the use of antidepressants, antipsychotics and antiepileptics are described [33].”
BackgroundGarnero, P., Borel, O., & Delmas, P. D. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.694 · Cited by 193 · cited 1×
“The parameters beta-CrossLaps (CTX), N-terminal propeptide of Type I collagen (PINP) and 25OH-vitamin D (25OHD) were measured in serum with electrochemiluminescence immunoassays (ECLIA) on the automated analyzer Elecsys 2010 (Roche Diagnostics, Rotkreuz, Switzerland) [27, 28].”
MethodAsomaning, K., Bertone-Johnson, E. R., Nasca, P. C., Hooven, F., & Pekow, P. S. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.1028 · Cited by 169 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundLi, M., Xu, Y., Xu, M., Ma, L., Wang, T., Liu, Y., Dai, M., Chen, Y., Lu, J., Liu, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3010 · Cited by 137 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundLow bone density in patients receiving methadone maintenance treatment
Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.027 · Cited by 131 · cited 3×
“Data on the effect of illicit drug use and substitution therapy on bone mass in men are limited due to the small number of men included in previous studies [4–6].”
BackgroundHypogonadism in men receiving methadone and buprenorphine maintenance treatment
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., & Attia, J. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00824.x · Cited by 124 · cited 2×
“Long-term opioid therapy for either addiction or chronic pain induces hypogonadism [17–21] due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropin-releasing hormone in the pituitary gland and impaired testicular function [23].”
BackgroundTestosterone suppression in opioid users: A systematic review and meta-analysis
Bawor, M., Bami, H., Dennis, B. B., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Steiner, M., Anglin, R., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.038 · Cited by 123 · cited 2×
“1 3 pain induces hypogonadism due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropins in the pituitary gland and impaired testicular function [22, 23].”
BackgroundOsteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications
Nakchbandi, I. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9427 · Cited by 105 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundEffect of Chronic Alcohol Ingestion on Bone Mineral Density in Males without Liver Cirrhosis
Kim, M. J., Shim, M. S., Kim, M. K., Lee, Y., Shin, Y. G., Chung, C. H., & Kwon, S. O. (2003) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2003.18.3.174 · Cited by 93 · cited 3×
“The negative association between alcohol intake and bone mass in our study is likely to be related to lower amounts of daily intake, supporting a dosedependent effect of alcohol on bone mass [8].”
BackgroundMalik, P., Gasser, R. W., Kemmler, G., Moncayo, R., Finkenstedt, G., Kurz, M., & Fleischhacker, W. W. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00847.x · Cited by 93 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundEffects of Age on Testicular Function and Consequences of Testosterone Treatment1
Snyder, P. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7602 · Cited by 73 · cited 1×
“Men with overt hypogonadism either due to organic testicular or hypothalamic–pituitary dysfunction or ageassociated androgen deficiency present with dose-dependent decreases in bone mass [25, 35].”
BackgroundTrautwein, C. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01061-3 · Cited by 73 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundSmoking predicts incident fractures in elderly men: Mr OS Sweden
Jutberger, H., Lorentzon, M., Barrett-Connor, E., Johansson, H., Kanis, J. A., Ljunggren, Ö., Karlsson, M. K., Rosengren, B. E., Redlund-Johnell, I., Orwoll, E., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091112 · Cited by 70 · cited 2×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
BackgroundDecreased bone density in men on methadone maintenance therapy
Grey, A., Rix‐Trott, K., Horne, A., Gamble, G., Bolland, M., & Reid, I. R. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03159.x · Cited by 61 · cited 3×
“Data on the effect of illicit drug use and substitution therapy on bone mass in men are limited due to the small number of men included in previous studies [4–6].”
BackgroundResultNguyen, H. V., Mollison, L. C., Taylor, T. W., Chubb, S. A. P., & Yeap, B. B. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01093.x · Cited by 55 · cited 1×
“Dysregulation of gonadal hormones with decreased free testosterone levels and increased serum levels for sex hormone-binding protein (SHBG) has also been shown in patients with compensated liver disease [37].”
BackgroundMethadone induces testosterone suppression in patients with opioid addiction
Bawor, M., Dennis, B. B., Samaan, M. C., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Desai, D., Steiner, M. S., et al. (2014) · Scientific Reports · doi:10.1038/srep06189 · Cited by 53 · cited 3×
“Long-term opioid therapy for either addiction or chronic pain induces hypogonadism [17–21] due to central suppression of hypothalamic secretion of gonadotropin-releasing hormone, decreased secretion of gonadotropin-releasing hormone in the pituitary gland and impaired testicular function [23].”
BackgroundGuechot, J., Chazouillères, O., Loria, A., Hannoun, L., Balladur, P., Parc, R., GIBOUDEAU, J., & Poupon, R. Y. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80020-0 · Cited by 52
Schmidt‐Gayk, H., Spanuth, E., Kötting, J., Bartl, R., Felsenberg, D., Pfeilschifter, J., Raue, F., & Roth, H. J. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.017 · Cited by 48 · cited 1×
“The parameters beta-CrossLaps (CTX), N-terminal propeptide of Type I collagen (PINP) and 25OH-vitamin D (25OHD) were measured in serum with electrochemiluminescence immunoassays (ECLIA) on the automated analyzer Elecsys 2010 (Roche Diagnostics, Rotkreuz, Switzerland) [27, 28].”
MethodOsteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications
Inaam, & Nakchbandi, V. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 41
Pignata, S., Daniele, B., Galati, M. G., Esposito, G., Vallone, P., Fiore, F., Ricchi, P., & Pergola, M. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199703000-00012 · Cited by 37 · cited 1×
“Testosterone deficiency is a recognized comorbidity in patients with decompensated cirrhosis and hepatocellular carcinoma [36].”
BackgroundCoronary Heart Disease (CHD) Risk Factors and Metabolic Syndrome in HIV-Positive Drug Users in Miami
Baum, M. K., Rafie, C. L., Lai, S., Xue, L., Sales, S., Page, J. B., Berkman, R., Karas, L. A., & Campa, A. L. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.173.179 · Cited by 34
Iturriaga, H. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.6.903 · Cited by 33 · cited 1×
“In liver failure, the rise in SHBG levels is assumed to result from induction by estradiol, increased liver SHBG synthesis or reduced SHBG clearance intrinsic to the liver disease itself [38–40].”
BackgroundPathogenesis of osteoporosis in liver cirrhosis.
Γιουλεμέ, Ό., Vyzantiadis, T., Nikolaidis, N. L., Vassiliadis, T. G., Papageorgiou, A. A., Eugenidis, N. P., & Harsoulis, F. (2006) · PubMed · Cited by 33
Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice
Keel, C., KRAENZLIN, M. E., Kraenzlin, C. A., Müller-Stich, B. P., & Meier, C. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0101-7 · Cited by 29 · cited 2×
“8 % for 25OHD [29].”
Self-citationBesi, L. D., Zucchetta, P., Zotti, S., & Mastrogiacomo, I. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200271 · Cited by 29 · cited 1×
“In liver failure, the rise in SHBG levels is assumed to result from induction by estradiol, increased liver SHBG synthesis or reduced SHBG clearance intrinsic to the liver disease itself [38–40].”
BackgroundDÜRSTELER-MACFARLAND, K. M., KOWALEWSKI, R., BLOCH, N., WIESBECK, G. A., KRAENZLIN, M. E., & STOHLER, R. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00242.x · Cited by 22 · cited 3×
“Data on the effect of illicit drug use and substitution therapy on bone mass in men are limited due to the small number of men included in previous studies [4–6].”
BackgroundSelf-citationNutritional Alterations in Drug Abusers With and Without HIV
Forrester, J. E. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.180.183 · Cited by 17 · cited 1×
“This might be due to life-style factors and comorbidities associated with long-term opioid consumption such as smoking [4, 7], alcohol intake [8–10], advanced liver disease and cirrhosis [11–14], and low body-mass index or malnutrition [15, 16].”
Background
Research works printed but not linked: 1
- Meier C, Seibel MJ, Handelsman DJ (2009) Testicular dysfunction and bone. In: Orwoll E, Bilezikian J, Vanderschueren D (eds) Osteoporosis in men, 2nd edn. Academic Press, San Diego, pp 423–434
Cited by
Golds, G., Houdek, D., & Arnason, T. (2017) · International Journal of Endocrinology · doi:10.1155/2017/4602129 · Cited by 150
“However, there are multiple potential contributors to decreased BMD and increased fractures in this population, though lower BMD was found to be associated with lower testosterone levels in one study [131].”
BackgroundBone fracture nonunion rate decreases with increasing age: A prospective inception cohort study
Zura, R., Braid‐Forbes, M. J., Jeray, K. J., Mehta, S. D., Einhorn, T. A., Watson, J. T., Rocca, G. J. D., Forbes, K. F., & Steen, R. G. (2016) · Bone · doi:10.1016/j.bone.2016.11.006 · Cited by 120
Effects of Neurological Disorders on Bone Health
Kelly, R. R., Sidles, S. J., & LaRue, A. C. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.612366 · Cited by 96
“The impact of alcohol addiction on bone has been well studied and will be the focus of this section, although opioid, cannabis, and amphetamine addictions have also been associated with decreased BMD and increased fracture risk (Gozashti et al., 2011; Mosti et al., 2016; Gotthardt et al., 2017; Heydari et al., 2017; S…”
BackgroundMuthulingam, D., Bia, J., Madden, L. M., Farnum, S. O., Barry, D. T., & Altice, F. L. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.01.019 · Cited by 85
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Metadata
- Authors
- Gotthardt, F., Huber, C., Thierfelder, C., Grize, L., Kraenzlin, M., Scheidegger, C., & Meier, C.
- Affiliations
- Swiss Tropical and Public Health Institute (CH)
- University Hospital of Basel (CH)
- Corresponding author
- Meier, Christian
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2016-01-08
- Volume
- 35
- Issue
- 1
- Pages
- 99-107
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2226189432
- Semantic Scholar
- 1e147efeb116c44d35d685fd4a81aa32b7143a58
- Cited by
- 55
- References
- 42
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 4
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Freiwillige Akademische Gesellschaft Basel (Switzerland)
- Verein für Drogenarbeit Basel (Switzerland)
- Roche Pharma (Switzerland)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- bone mineral density, opioid use disorder, opioid substitution therapy, osteopenia, osteoporosis, free testosterone, androgen deficiency, men, methadone, buprenorphine, morphine, fracture risk, falls
- MeSH terms
- Adult, Age Factors, Bone Diseases, Metabolic, Humans, Male, Middle Aged, Opioid-Related Disorders, Osteoporosis, Switzerland, Biomarkers, Bone Density, Fractures, Bone, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.